Disclosure 0001273351-26-000006-2

SEC FORM 4

$796,209.04

Dianthus Therapeutics, Inc. /DE/ (DNTH)

Sale of 7,928 shares at $100.43 per share.

Reporting Person CARR EDWARD · Officer Title CHIEF ACCOUNTING OFFICER · Transaction Code S

Traded Sep 17, 2026 · Disclosed Sep 18, 2026

Source: SEC Form 4 · 0001273351-26-000006 · filed 2026-09-18 · View filing →

Composed from the Form 4 as filed with the SEC. Share counts, prices and dates are the filing's own; the disclosure lag is counted in business days from the transaction date to the filing date. What is a Form 4?

Cite this card

Desq Long. "Dianthus Therapeutics, Inc. /DE/ (DNTH)." Disclosed 2026-09-18. https://desqlong.com/cards/0001273351-26-000006-2 (retrieved 2026-09-26).